1654P TAMARACK: Randomized Phase II trial of the B7-H3 targeting antibody drug conjugate (ADC) vobramitamab duocarmazine (vobra duo) in metastatic castration-resistant prostate cancer (mCRPC)

J.S. de Bono, Carole Hélissey, K. Fizazi, J.P. Maroto Rey, Guilhem Roubaud, Emmanuel S. Antonarakis, Shahneen Sandhu, N.D. Shore, R. Ratta, Begoña P. Valderrama, Christof Vulsteke, Lisa Schäfer, G. Marr, Eric Y. Stutheit-Zhao, Alex Ward, J.M. Piulats Rodriguez